StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth total assets

Total assets on the balance sheet at the end of each period.

Vireo Growth's total assets was $1.42B at Sep 30, 2026. For fiscal 2025 it was $817.20M, up 193.0% from the year before. The highest annual figure on record is $817.20M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$817.20M+193.0%
FY2024Dec 31, 2024$278.86M+52.2%
FY2023Dec 31, 2023$183.26M+15.1%
FY2022Dec 31, 2022$159.16M-4.7%
FY2021Dec 31, 2021$166.97M+62.7%
FY2020Dec 31, 2020$102.63M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.42B+109.8%
Q2 FY2026Jun 30, 2026$1.27B+93.2%
Q1 FY2026Mar 31, 2026$928.80M+235.3%
Q4 FY2025Dec 31, 2025$817.20M+193.0%
Q3 FY2025Sep 30, 2025$678.92M+250.2%
Q2 FY2025Jun 30, 2025$659.34M+238.7%
Q1 FY2025Mar 31, 2025$277.05M+45.1%
Q4 FY2024Dec 31, 2024$278.86M+52.2%
Q3 FY2024Sep 30, 2024$193.87M+12.9%
Q2 FY2024Jun 30, 2024$194.68M+17.3%
Q1 FY2024Mar 31, 2024$190.88M+20.3%
Q4 FY2023Dec 31, 2023$183.26M+15.1%
Q3 FY2023Sep 30, 2023$171.67M-1.0%
Q2 FY2023Jun 30, 2023$165.95M-1.7%
Q1 FY2023Mar 31, 2023$158.63M-1.3%
Q4 FY2022Dec 31, 2022$159.16M-4.7%
Q3 FY2022Sep 30, 2022$173.32M+5.6%
Q2 FY2022Jun 30, 2022$168.82M+49.8%
Q1 FY2022Mar 31, 2022$160.73M+30.2%
Q4 FY2021Dec 31, 2021$166.97M+62.7%
Q3 FY2021Sep 30, 2021$164.16M–
Q2 FY2021Jun 30, 2021$112.68M–
Q1 FY2021Mar 31, 2021$123.45M–
Q4 FY2020Dec 31, 2020$102.63M–

More Vireo Growth figures

See a number that looks wrong?